| Sources | Names Used |
|---|---|
| CTRPv2 | compound 1B |
| PharmacoGx | compound 1B |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHRNB1 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | NPM3 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |
| mRNA | LIG1 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.03 |
| mRNA | MGST2 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | ACTR8 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.03 |
| mRNA | NDUFB5 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
| mRNA | ATG7 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | WDR74 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.03 |
| mRNA | PPP4C | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | A4GALT | CTRPv2 | pan-cancer | AAC | 0.089 | 0.03 |
